PMID: 2497467May 1, 1989Paper

Role of endothelium-derived nitric oxide in the regulation of blood pressure

Proceedings of the National Academy of Sciences of the United States of America
D D ReesS Moncada

Abstract

The role of endothelium-derived nitric oxide in the regulation of blood pressure in the anesthetized rabbit was studied with N omega-monomethyl-L-arginine (L-NMMA), a specific inhibitor of its formation from L-arginine. L-NMMA (3-100 mg.kg-1), but not its D-enantiomer, induced a dose-dependent long-lasting (15-90 min) increase in mean systemic arterial blood pressure. L-NMMA (100 mg.kg-1) also inhibited significantly the hypotensive action of acetylcholine, without affecting that of glyceryl trinitrate. Both these actions of L-NMMA were reversed by L-arginine (300 mg.kg-1), but not by D-arginine (300 mg.kg-1), indomethacin (1 mg.kg-1), prazosin (0.3 mg.kg-1), or by vagotomy. The effects of L-NMMA in vivo were associated with a significant inhibition of the release of nitric oxide from perfused aortic segments ex vivo. This inhibition was reversed by infusing L-arginine through the aortic segments. These results indicate that nitric oxide formation from L-arginine by the vascular endothelium plays a role in the regulation of blood pressure and in the hypotensive actions of acetylcholine.

References

Nov 13, 1987·Biochemical and Biophysical Research Communications·M W RadomskiS Moncada
Dec 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·L J IgnarroG Chaudhuri
May 1, 1988·Clinical and Experimental Pharmacology & Physiology·C G SobeyG J Dusting
Jul 15, 1988·Biochemical and Biophysical Research Communications·M KelmJ Schrader
Nov 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·I SakumaR Levi
Sep 13, 1988·European Journal of Pharmacology·H H SchmidtE Böhme
Jun 30, 1988·Biochemical and Biophysical Research Communications·R M PalmerS Moncada
Dec 15, 1986·Biochemical and Biophysical Research Communications·G ThomasP W Ramwell
Jan 1, 1984·Annual Review of Pharmacology and Toxicology·R F Furchgott
Apr 12, 1984·Nature·T M GriffithA H Henderson
Oct 1, 1984·Journal of Hypertension·R J WinquistA A Wallace

❮ Previous
Next ❯

Citations

Feb 24, 2000·The Journal of Pathology·H Li, U Förstermann
Jun 1, 1993·Journal of Clinical Pharmacology·M Gibaldi
Aug 1, 1993·Naunyn-Schmiedeberg's Archives of Pharmacology·M Inazu, M Tujitani
Jun 1, 1995·Pflügers Archiv : European journal of physiology·J WagnerE Ritz
Feb 1, 1992·Pflügers Archiv : European journal of physiology·M SonntagJ Schrader
Nov 1, 1993·Biulleten' eksperimental'noĭ biologii i meditsiny·V I Shebeko, Iu Ia Rodionov
Sep 3, 1991·Klinische Wochenschrift·T F Lüscher, H A Bock
Oct 1, 1995·Digestive Diseases and Sciences·X LiuH Nawata
Jan 1, 1997·Journal of Biomedical Science·H.I. ChenD. Wang
Apr 25, 2003·Journal of Biomedical Science·Alice Y W ChangSamuel H H Chan
Jan 1, 1994·Research in Experimental Medicine. Zeitschrift Für Die Gesamte Experimentelle Medizin Einschliesslich Experimenteller Chirurgie·A FazekasD R Richardson
Jul 27, 2005·Archives of Pharmacal Research·Kwang-Ok LeeYoung-Ger Suh
Nov 18, 1998·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·I Mayers, D Johnson
Nov 15, 2011·Naunyn-Schmiedeberg's Archives of Pharmacology·Craig Comiter
May 12, 2007·International Archives of Occupational and Environmental Health·Robert DalesTerrence D Ruddy
Mar 10, 2010·Pflügers Archiv : European journal of physiology·Dragomir N SerbanPaul M Vanhoutte
Apr 5, 2001·Current Atherosclerosis Reports·J P Cooke, R K Oka
Feb 15, 2001·Current Hypertension Reports·F Cosentino, T F Lüscher
Nov 22, 2001·Current Hypertension Reports·L V d'Uscio, T F Lüscher
Jan 18, 2003·Current Hypertension Reports·Malte Kelm
Dec 1, 1995·The Annals of Thoracic Surgery·R D CurranD L Wessel
Feb 15, 1991·Biochemical Pharmacology·L J Ignarro
Oct 24, 1989·European Journal of Pharmacology·G ThomasP W Ramwell
Dec 19, 1989·European Journal of Pharmacology·J M PiqueJ V Esplugues
Jul 17, 1990·European Journal of Pharmacology·J A MitchellJ R Vane
Aug 21, 1990·European Journal of Pharmacology·N P WiklundP Hedqvist
Sep 21, 1990·European Journal of Pharmacology·I D DurateS H Ferreira
Jun 21, 1990·European Journal of Pharmacology·Z B FortesD Nigro

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.